NASDAQ · CTNM
Contineum Therapeutics, Inc. Class A Common Stock
Healthcare · Biotechnology
$9.69
Up+$0.10 (+1.03%)
Updated Nov 4, 2026, 11:48 PM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 383.14M
- P/E ratio
- -6.22
- Dividend yield
- 0.00%
- 52-week range
- $6.73 – $17.79
- Volume
- 526.34K
- Avg. volume
- 158.83K
Price performance · CTNM
CTNM price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
CTNM closed at $9.69 after 21 trading sessions, down 23.40% for the selected period.
- Last close
- $9.69
- Period change
- -23.40%
- Period low
- $7.08
- Period high
- $13.38
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $9.57 | $9.94 | $9.54 | $9.69 | 526.34K |
| Nov 2, 2026 | $9.46 | $9.64 | $9.13 | $9.56 | 369.01K |
| Oct 30, 2026 | $9.14 | $9.58 | $8.93 | $9.39 | 458.62K |
| Oct 29, 2026 | $9.13 | $9.865 | $9.13 | $9.33 | 566.92K |
| Oct 28, 2026 | $8.92 | $9.34 | $8.59 | $9.15 | 570.48K |
| Oct 27, 2026 | $8.18 | $9.12 | $8.02 | $8.99 | 643.75K |
| Oct 26, 2026 | $8.25 | $8.59 | $8.02 | $8.14 | 402.68K |
| Oct 23, 2026 | $8.24 | $8.43 | $8.01 | $8.31 | 428.77K |
| Oct 22, 2026 | $8.32 | $8.7499 | $8.12 | $8.395 | 498.75K |
| Oct 21, 2026 | $8.49 | $8.79 | $8.15 | $8.35 | 1.12M |
| Oct 20, 2026 | $7.38 | $8.70 | $7.145 | $8.46 | 2.2M |
| Oct 19, 2026 | $7.01 | $7.45 | $6.725 | $7.44 | 1.8M |
| Oct 16, 2026 | $7.87 | $7.87 | $6.95 | $7.08 | 1.11M |
| Oct 15, 2026 | $8.25 | $8.56 | $7.72 | $7.90 | 1.02M |
| Oct 14, 2026 | $8.21 | $8.7955 | $7.96 | $8.14 | 1.01M |
| Oct 13, 2026 | $8.56 | $8.94 | $8.095 | $8.42 | 2.65M |
| Oct 12, 2026 | $9.90 | $11.54 | $8.425 | $8.565 | 8.47M |
| Oct 9, 2026 | $13.17 | $13.855 | $12.94 | $13.38 | 885.59K |
| Oct 8, 2026 | $12.55 | $13.29 | $12.39 | $13.18 | 1.18M |
| Oct 7, 2026 | $12.42 | $13.01 | $12.31 | $12.73 | 707.73K |
| Oct 6, 2026 | $12.88 | $12.88 | $12.17 | $12.65 | 761.92K |
Latest CTNM news
The latest Smart Investors Daily articles mentioning CTNM.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

